bullish
Suzhou Basecare Medical IPO: First Mover with the Only NMPA-Approved PGT Product in China
344 Views27 Jan 2021 03:17
The Chinese genetic testing solutions provider for assisted reproduction, Suzhou Basecare Medical has filed for an IPO to list its shares on the Hong Kong Stock Exchange.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Apple: 1Q FY09/21 Earnings Set New All-Time Records28 Jan 2021
- CyberAgent: Game Business Continues to Disappoint but Internet Ad and ABEMA Performs Steadily28 Jan 2021
- Suzhou Basecare Medical IPO Valuation: Attractive Even at the Upper End of the IPO Pricing28 Jan 2021
- Suzhou Basecare Medical IPO: First Mover with the Only NMPA-Approved PGT Product in China27 Jan 2021
- Kuaishou IPO Valuation: Attractive Valuation25 Jan 2021
- JD Health IPO Trading Update: Be Ready to Buy if It Drops Post Index Inclusion21 Dec 2020
- Hygeia Healthcare IPO (Part I): A Better Healthcare16 Jun 2020
x